Furthermore, the downregulation of LINC01564 has been associated with genomic instability and metabolic adaptation in liver cancer, while SLC26A3 has been linked to inflammatory bowel disease and infectious diarrhea (Yu, 2021; Zhang et al., 2021; Chen et al., 2022). Here, LINC01564 is linked to liver cancer.